Pacira BioSciences Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Pacira Pharma (PCRX) Misses Q2 EPS by 35c
August 3, 2022 8:06 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q2 EPS of $0.53, $0.35 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $169.4 million versus the consensus estimate of $172.22 million.
For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.
... More